More Uncertainty For Biopharma Players As China Economic Growth Falters

30% Of EU Businesses Report Revenue Decline

 
• By Brian Yang
  
China NDA in 2021 sized 1200
China's faltering economy adds new uncertainty for foreign health sector players • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia